TY  - CONF

T1  - SPIRE: A phase Ib/randomised IIa open label clinical trial combining guadecitabine (SGI-110) with cisplatin and gemcitabine chemotherapy for solid malignancies including bladder cancer.

JO  - Journal of Clinical Oncology

PY  - 2018/05/20

AU  - Crabb SJ

AU  - Danson S

AU  - Catto J

AU  - McDowell C

AU  - Dunkley D

AU  - Huddart RA

AU  - Griffiths G

ED  - 

DO  - DOI: 10.1200/jco.2018.36.15_suppl.tps4594

PB  - American Society of Clinical Oncology (ASCO)

VL  - 36

IS  - 15_suppl

SP  - TPS4594

EP  - TPS4594

Y2  - 2024/12/26

ER  -